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and IP4) to IP3. Cheng and Andrew have
demonstrated that Drosophila Mipp1 is
highly expressed in cells of migrating
branches of the developing trachea
where it functions extracellularly to
facilitate filopodia formation and confer
migratory advantage.
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Multiple inositol polyphosphate phosphatase (Mipp),
a highly conserved but poorly understood histidine
phosphatase, dephosphorylates higher-order IPs
(IP4–IP6) to IP3. To gain insight into the biological roles
of these enzymes, we have characterized Drosophila
mipp1.mipp1 is dynamically expressed in the embry-
onic trachea, specifically in the leading cells of
migrating branches at late stages, whereMipp1 local-
izes to the plasma membrane and filopodia. FGF
signaling activates mipp1 expression in these cells,
where extensive filopodia form to drive migration
and elongation by cell intercalation. We show that
Mipp1 facilitates formation and/or stabilization of filo-
podia in leading cells through its extracellular activity.
mipp1 loss decreases filopodia number, whereas
mipp1 overexpression increases filopodia number in
a phosphatase-activity-dependent manner. Impor-
tantly, expression of Mipp1 gives cells a migratory
advantage for the lead position in elongating tracheal
branches. Altogether, these findings suggest that
extracellular pools of inositol polyphosphates affect
cell behavior during development.
INTRODUCTION
Inositol polyphosphates (IPs) are important second messengers
involved in diverse cellular processes. Cytosolic IPs control ion
channel physiology, membrane dynamics, and cell migration
(Irvine and Schell, 2001), whereas nuclear IPs have functions in
mRNA export and gene regulation (York, 2006). The roles of
extracellular IPs have been less thoroughly explored. Intracel-
lular IPs are synthesized in the cell and extracellular IPs are ob-
tained from the diet (Grases et al., 2005). For both intracellular
and extracellular IPs, inositol hexakisphosphate (IP6) or phytate,
is the most abundant, reaching intracellular concentrations of
10–100 mM (Sasakawa et al., 1995). IP6 can form tight insoluble
complexes with a number of cations, including calcium, magne-
sium, iron, and zinc, and thus serves as a storage molecule for
inositol, phosphorus, and minerals (Kumar et al., 2010; Vucenik
and Shamsuddin, 2006). IP6 is a well-known anti-tumor agent2174 Cell Reports 13, 2174–2188, December 15, 2015 ª2015 The Aufound in high-fiber foods and sold in many health food stores
(Vucenik and Shamsuddin, 2003). High concentrations of extra-
cellular IP6 inhibit cell migration and proliferation in human breast
cancer cells (Shamsuddin et al., 1997) and induce G1 arrest and
apoptotic death of pancreatic cancer cells (Singh et al., 2003).
Maintenance of IP6 at critical threshold levels is important for
mouse development (Verbsky et al., 2005).
Mipp (Multiple Inositol Polyphosphate Phosphatase) is the
major phosphatase that dephosphorylates IP6 to lower order
IPs (IP5, IP4, and IP3). Mipp is a highly conserved histidine phos-
phatase with clear orthologs in all animals (Figures 1A and 1B).
The key catalytic residues of the Mipp histidine phosphatase
are RHG-R-H, which are brought together into a catalytic pocket
(Figures 1C and 1D). Mipp homologs in plants and microorgan-
isms are known as phytases, secreted histidine phosphatases
that dephosphorylate extracellular IP6. Mammalian Mipp local-
izes to the ER lumen (Ali et al., 1993; Chi et al., 2000) as well as
to the erythrocyte plasma membrane (Estrada-Garcia et al.,
1991). Since manipulation of Mipp levels in mouse embryonic fi-
broblasts changes the cytosolic IP profile, Mipp may have ac-
cess to cytosolic pools (Chi et al., 2000). Recent studies reveal
that mammalian Mipp, like phytase, is secreted in certain cells
(Windhorst et al., 2013), suggesting that Mipp may have intracel-
lular and extracellular functions.
Mipp is ubiquitously expressed in mammalian tissues, with
elevated levels in growth plate chondrocytes, suggesting a po-
tential role in chondrocyte differentiation (Craxton et al., 1995,
1997). Although Mipp is the major phosphatase known to
convert IP6 to IP3, mipp knockout mice are viable and fertile,
without obvious defects (Chi et al., 2000). The characterization
of erythrocytes from these mutants, however, suggests that
Mipp activity is compensated by another unknown enzyme
(Chi et al., 2000).
The observation that all animals encode at least one mipp
gene argues for a fundamental, undiscovered biological function
for this enzyme. Drosophila encodes two mipp genes: mipp1
and mipp2. Whereas mipp2 is ubiquitously expressed (data
not shown), mipp1 shows tissue-specific expression, including
high and dynamic Trachealess-dependent expression in the
developing embryonic trachea (embryonic stages [st] 10–15)
(Figures S1A–S1O) (Chung et al., 2011). Tracheal development
initiates with ten epithelial plates (placodes) of 40 cells each
on both sides of the embryo (Maruyama and Andrew, 2012).
Each placode invaginates as tracheal cells undergo their finalthors
Figure 1. Mipp1 Encodes a Highly Conserved Histidine Phosphatase with Active Site Residues Dispersed throughout the Coding Region
(A and B) Textshade alignment (A) and Unrooted Phylip Tree (B) of Mipps and Phytases from representative model organisms.
(C) Phyre2 predicted structure of Drosophila Mipp1.
(D) Phyre2 predicted configuration of active site residues (black arrows in A) in the active site pocket of Drosophila Mipp1.
Dr,Danio rerio; Mm,Musmusculus; Hs,Homo sapiens; Dd,Dictyostelium discoideum; Ag, Anopheles gambiae; Dm,Drosophila melanogaster; Cf,Cryptococcus
neoformans; An, Aspergillis nigers.mitotic division to generate an internalized tracheal sac of 80
cells. Five primary branches subsequently form in each tracheal
segment (metamere), including the dorsal branch (DB), dorsal
trunk (DT), visceral branch (VB), lateral trunk (LT), and ganglionic
branch (GB). Fibroblast growth factor (FGF) signaling at the ends
of branches drives filopodia formation to facilitate branch forma-
tion, elongation, and migration (Figure S2) (Kla¨mbt et al., 1992;
Ohshiro et al., 2002; Okenve-Ramos and Llimargas, 2014; Ri-
beiro et al., 2002; Sutherland et al., 1996). During st14, cells at
the ends of the DT in each segment meet up and fuse with their
partner cells in anterior and posterior segments to form an inter-
connected branch that runs along the length of the embryo.
Other branches continue tomigrate and elongate until they reachCell Reptheir final destinations; these branches elongate by transforming
from multicellular tubes into unicellular tubes though a cell rear-
rangement process known as stalk cell intercalation or SCI (Fig-
ure S2B) (Ribeiro et al., 2004). By the end of development, the
trachea has formed an elaborate interconnected branched
network to provide gas exchange for every tissue of the animal.
To gain insight into the biological function of Mipps, we char-
acterized Drosophila Mipp1. We showed that Mipp1 is dynami-
cally expressed in migrating tracheal branches with FGF-depen-
dent enrichment at the distal tip, where filopodia form. We
learned that Mipp1 localizes to the filopodia and to the plasma
membrane, where it converts extracellular IP6 to IP3. To deter-
mine the extracellular functions of Mipp1 in vivo, we created aorts 13, 2174–2188, December 15, 2015 ª2015 The Authors 2175
null allele ofmipp1 and constructs for overexpression. Our anal-
ysis revealed that Mipp1 facilitates filopodia formation and that
expression of Mipp1 gives migrating tracheal cells a competitive
advantage for the lead position in an extracellular phosphatase
activity-dependent manner.
RESULTS
mipp1mRNA Is Dynamically Expressed and Enriched at
the Distal Tip of Migrating Tracheal Branches
mipp1 expression was observed in all tracheal cells from embry-
onic st10 to st12 (Figures 2A and 2B). From st13 to st15, mipp1
levels were diminished in the DT and maintained in the DB,
VB, LT, and GB—branches that undergo extensive migration
and elongation (Figures 2C and 2D). Fluorescent in situ hybridi-
zation revealed mipp1 accumulation in small puncta dispersed
throughout the cytoplasm with some enrichment near the
plasma membrane during st10–st12 (Figures 2F and 2G). During
st13–st15, mipp1 accumulated in a large focus localized to one
side of the cell for DBs, VBs, and LTs/GBs. For DBs, which
migrate dorsally, mipp1 mRNA foci localized to the dorsal sides
of the two to three most distal tip cells (Figure 2H). For VBs,
which migrate inwardly,mipp1mRNA foci localized to the basal
side of every cell (Figure 2J). For LTs/GBs, which migrate
ventrally, mipp1 mRNA foci localized to the ventral side of
each cell (Figure 2K). Similar large foci of mRNA accumulation
were not observed with two other tracheal genes, sano and
trh, which encode an apically enriched cytosolic protein and a
nuclear transcription factor, respectively (Figures S1Q and
S1R). mipp1 mRNA expression/localization coincides with the
onset and localization of filopodia formation in the trachea.
Extensive filopodia were visible from st13 at the distal side of
the most distal DB cells, on the basal side of VB cells, and the
ventral side of LT/GB cells (Figure S1S). We conclude that
mipp1 mRNA is maintained in migrating branches with enrich-
ment at regions where extensive filopodia form.
Mipp1 Protein Localizes to the PlasmaMembrane and to
Filopodia
To learn the endogenous cellular localization of Drosophila
Mipp1, Mipp1-specific antiserum was generated (Figures S3A–
S3E). Mipp1 protein expression (Figures S3F–S3P) paralleled
mipp1 mRNA expression (Figures S1A–S1L). Mipp1 localized to
the plasma membrane, showing no overlap with the ER marker
KDEL (Figure S3Q). During invagination (st10), Mipp1 preferen-
tially localized to the apical surface (Figure 3A). During primary
branching (st11), Mipp1 localization shifted to the basolateral
domain (Figure 3B). At late stages (st13–st15), Mipp1 was en-
riched at the distal ends of DB (Figure 3C) and LT/GB cells (Fig-
ure 3E), thebasal side of VBcells (Figure 3D), in cell-cell junctions,
and in filopodia-like structures of these branches (Figures 3C–
3E). Filopodial structures at the distal tip of the DB have been
characterized by live in vivo imaging (Okenve-Ramos and Llimar-
gas, 2014; Ribeiro et al., 2002); both F-actin and fascin (Singed)
localize to these structures. We observed F-actin (Figures 3F–
3F0 0 0), fascin (Singed) (Figures 3G–3G0 0 0) and other filopodia
markers – formin (Enable/Vasp) (Figures 3H–3H0 0 0) and profilin
(Chickadee) (Figures 3I–3I0 0 0) in the Mipp1-stained-filopodia-like2176 Cell Reports 13, 2174–2188, December 15, 2015 ª2015 The Austructures, indicating that they are filopodia. Mipp1 overlapped
with Chickadee at all stages (Figures 3J–3O); both proteins
were highly enriched in the apical domain at st10 (Figure 3J),
shifted to basolateral during st11 (Figure 3K), were enriched at
cell-cell junctions and distal tips of the DB, VB, and LT/GB at
st14 (Figures 3L, 3N, and 3O; yellow arrowheads), and localized
to filopodia (Figures 3L, 3N, and 3O; white arrowheads). Similar
Mipp1-stained-filopodia-like structures were observed when
mipp1 was expressed in the embryonic salivary gland (another
epithelial organ) (Figure S4A) and in S2 cells (Figures S4G–S4G0 0).
FGF Signaling Regulates Mipp1 Expression
FGF signaling guides tracheal branch migration (Kla¨mbt et al.,
1992; Ohshiro et al., 2002; Sutherland et al., 1996). The FGF re-
ceptor Breathless (Btl) is expressed in tracheal cells, and the
FGF ligand Branchless (Bnl) is expressed in tissues towardwhich
tracheal cells migrate. Activated FGF signaling at the tips of
migrating branches induces filopodia formation (Ghabrial and
Krasnow, 2006; Ribeiro et al., 2002). Since themipp1 expression
pattern is similar to the pattern of activated FGF signaling,
we asked whether mipp1 expression is downstream of FGF
signaling. In WT late-stage embryos,mipp1mRNAwas enriched
at the distal tip of the DB and detected only at low levels in the DT
(Figures 4A, 4A0, 4J, and 4K). In btlLG19 or bnlP1mutants, in which
branchmigration is inhibited andonly rudimentary branches form
(Kla¨mbt et al., 1992; Sutherland et al., 1996), mipp1 mRNA and
protein levels were reduced and the large foci ofmipp1 accumu-
lation were not observed (Figures 4B and 4C). Ectopic overex-
pression of Bnl in epidermal stripes resulted in high levels of
mipp1 in the DT and proximal DB, with large mRNA puncta on
the side of cells close to the new source of Bnl (Figures 4D–4F).
The high levels of Bnl expression were linked to failures in DB for-
mation (Figure 4D) and elongation (Figure 4E). Knirps (Kni) and
Knirps-related (Knrl) are transcription factors downstream of
FGF signaling that are required for DB, VB, and LT/GB migration
(Chen et al., 1998; Myat et al., 2005). mipp1 mRNA was
decreased in Df(3L)ri79c (a deficiency removing both kni and
knrl) (Figure 4I). InDB, VB, and LT/GB,Kni/Knrl is also responsible
for suppressing Spalt (Sal), the transcription factor that promotes
DB elongation and suppresses SCI in the DT (K€uhnlein and
Schuh, 1996; Ribeiro et al., 2004). Suppression of Sal is required
for DB, VB, and LT/GB elongation by SCI. In Df(2L)Exel6029 (a
deficiency removing sal), DT elongation was blocked, and the
large foci of mipp1 accumulation at the distal tip of the DB (Fig-
ure 4G) and small intense punctate mipp1 staining near the
plasma membrane in the DT region (Figure 4G0) was observed.
Correspondingly, overexpression of Sal throughout the trachea
resulted in low levels of mipp1 mRNA and protein expression in
all branches (Figure 4H). Thus, FGF signaling upregulates
mipp1 in the DB, VB, and LT/GB, where extensive filopodia
form to drive branch migration and elongation by SCI; Spalt sup-
presses mipp1 expression in the DT, where minimal filopodia
form and branches elongate by other mechanisms (Figure 4L).
The Mipp1 HP Domain Faces Outside the Cell and
Dephosphorylates Extracellular IPs
WeaskedwhetherMipp1 functionson the intracellularorextracel-
lular side of the plasmamembrane. Mipp1 contains anN-terminalthors
(legend on next page)
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signal sequence, a histidine phosphatase (HP) domain, and a
putative C-terminal transmembrane (TM) domain (predicted by
MemBrain) with a presumptive GPI anchor site (predicted by
big-PI Predictor) (Figure 5A). CandidateMipp1 topologies include
a C-terminal TM-tethered protein with an intracellular HP domain
and a C-terminal TM-tethered or GPI-anchored protein with an
extracellular HP domain (Figure 5B). The Mipp1 HP domain con-
tains three predicted N-glycosylation sites (Figure 5B). N-glyco-
sylation occurs in the ER lumen, which is topologically equivalent
to the extracellular side of the plasma membrane. Glycosidase
treatment, which removes the N-glycan group, of extracts from
WT embryos (Figure 5C) and S2 cells expressing Mipp1 (Fig-
ure 5D), revealed a mobility shift on westerns, indicating that
Mipp1 is glycosylated. Thus, the HP domain faces outside the
cell. Mipp1 staining of unpermeabilized Mipp1-expressing S2
cells detected Mipp1 on the cell surface, confirming the extracel-
lular localization of Mipp1 (Figure 5E).
To learn whether Mipp1 is GPI anchored, we treated S2 cells
expressing Mipp1 with PI-PLC, which cleaves the GPI-anchor
and releases GPI-anchored proteins on the plasma membrane
into the extracellular media. Western blot analysis revealed the
appearance of the Mipp1 protein band in the supernatant frac-
tion upon treatment with PI-PLC (Figure 5F). Thus, Mipp1 is
GPI anchored in S2 cells. To determine whether Mipp1 is also
GPI anchored in vivo, we generated a C-terminal GFP tagged
Mipp1 (Mipp1-GFP) and observed localization of the GFP and
Mipp1 in a mipp1-null background. GPI modification occurs in
the lumen of the ER, where the C-terminal-TM domain of a target
protein is cleaved and the remaining portion is transferred to
the pre-assembled GPI moiety. If Mipp1 is GPI anchored in the
trachea, we expect the GFP to be in the ER andMipp1 to be traf-
ficked to the plasma membrane. We observed retention of GFP
in the ER (Figures 5I and 5J) with Mipp1 localizing to only the api-
cal membrane (Figure 5I). Compared to untaggedMipp1 and un-
tagged enzyme-dead Mipp1H67A, which localized to both apical
and basolateral plasma membrane domains (Figures 5G and
5H), Mipp1-GFP lacked the basolateral pool. Similar localization
patterns were observed with expression of the same UAS con-
structs in the salivary gland, another polarized epithelial tubular
organ that does not normally express mipp1 (Figures S4A–
S4E). Deleting the GPI anchor site of Mipp1 also trapped
Mipp1 in the ER (Figures S4F and S4K). An explanation for the
lack of a basolateral pool of Mipp1-GFP is that the C-terminal-
tagged-GFP allows GPI-anchored Mipp1 to be trafficked to the
apical membrane but traps the Mipp1 that does not undergo
the GPI modification in the ER. If this hypothesis is correct,
then the apical pool of Mipp1 is GPI anchored and the basolat-
eral pool of Mipp1 is likely to be transmembrane tethered. Alter-
native splicing can generate an apically localized GPI-anchoredFigure 2. mipp1 Is Dynamically Expressed in the Trachea with Late Tra
(A–D) In situ hybridization of mipp1 mRNA in st10–st15 WT embryos (lateral view
(E) Cartoon images showing tracheal metamere with labeled branches indicated b
[DT], red; visceral branches [VB], orange; lateral trunks/ganglionic branches [LT/
(F–K) Fluorescent in situ hybridization of st10–st14 embryos detectingmipp1mRN
tracheal nuclear marker.
Asterisks (*), trapping of mRNA probes in st14 trachea, a frequent occurrence wi
yellow arrowheads, small puncta of mipp1 mRNA; white dash lines, outline of th
2178 Cell Reports 13, 2174–2188, December 15, 2015 ª2015 The Auisoform and a basolaterally localized transmembrane-tethered
isoform of the same protein (e.g., N-CAM [Powell et al., 1991])
or one protein isoform can either undergo GPI-anchor modifica-
tion or remain as transmembrane tethered, regulated by an un-
known mechanism (e.g., ULBP2 [Ferna´ndez-Messina et al.,
2011]). Since the three alternative mipp1 mRNAs translate the
identical protein sequence, the second scenario is likely for
Mipp1.
We next testedwhether Mipp1 dephosphorylates extracellular
IPs. IP6 was added to the media of S2 cells transfected with the
vector, Mipp1, enzyme-dead Mipp1H67A, or C-terminal CFP-
tagged Mipp1, which all trafficked to the cell surface (Figures
S4G–S4J). After 30 min, media were collected and electrophor-
esed in high-percentage polyacrylamide gels that were stained
with toluidine blue to detect the IP bands. Dephosphorylation
of IP6 to lower order IPs was observed only in the media from
S2-Mipp1 and S2-Mipp1-CFP (Figure 5L). We conclude that
Mipp1 HP domain localizes to the extracellular side of the
plasma membrane and dephosphorylates extracellular IPs.
Mipp1 Affects Tracheal Morphogenesis
To elucidate the extracellular function of Mipp1 in trachea, we
generated amipp1KO by homologous recombination (Figure S5).
Staining with the 2A12 lumenal marker revealed that tracheal
morphology was largely normal in mipp1KO, with a few excep-
tions. In mipp1KO, the DTs were significantly elongated (Figures
6B and 6C), the percentage of DBs that had fused with their
contralateral partners was significantly decreased (Figures 6E,
6E0, and 6L), and a small, statistically insignificant percentage
of GBs failed to reach their targets in the CNS (Figures 6I and
6M). Similar tracheal phenotypes were observed in embryos
deficient for mipp2 (Df(X)N73) (Figures 6F, F0, 6J, 6L, and 6M).
Since these embryos had significant DT breaks, we did not mea-
sure DT length. Embryos simultaneously deficient formipp2 and
null for mipp1 (Df(X)N73; mipp1KO) exhibited significantly
increased severity of DB and GB defects (Figures 6G, 6G0, and
6K–6M), suggesting that the two proteins could have redundant
tracheal functions.
The elongated DT phenotype has also been observed with
mutations in septate junction proteins, in enzymes involved in
chitin synthesis, secretion, or deacetylation, in apical determi-
nant proteins such as Crb, and in components of the PCP
pathway (Chung et al., 2009; Laprise et al., 2010; Luschnig and
Uv, 2014; Tonning et al., 2005; Wang et al., 2006). We examined
the septate junction proteins Dlg (data not shown) and Coracle
(Figure S6B), chitin (Figure S6D), chitin deacetylase (Verm) (Fig-
ure S6F), andCrb accumulation (Figure S6H) and did not observe
abnormalities inmipp1KO. We also did not observe PCP defects
in mipp1KO (data not shown) or with mipp1 overexpression innscripts Concentrated in Large Foci on the Distal Side of Each Cell
s).
y color at multiple embryonic stages. (Dorsal branches [DB], blue; dorsal trunks
GB], green).
A (green) in combination with antibody staining for Mipp1 (red) and Tgo (blue), a
th in situ of later stage embryos; white arrowheads, large foci of mipp1 mRNA;
e trachea. Scale bars, 5 mm. See also Figure S1.
thors
Figure 3. Mipp1 Localizes to Different Plasma Membrane Domains and to Filopodia
(A–E) Mipp1 (red) and apical Crb (green) staining in st10–st14 embryos (projection images).
(F–I) Mipp1 (red) staining overlaps with filopodial markers, including (F–F0 0 0) lifeact-GFP, an F-actin marker, (G–G0 0 0) Fascin, (H–H0 0 0) Formin, and (I–I0 0 0) Profilin.
(J–O) Mipp1 (red) staining overlaps with Profilin (green) staining in (J) apical domain at st10, in (K) basolateral domain at st11, in filopodia and in tracheal branches
at st14 (L) DB, (N) VB, and (O) LT/GB (projection images).
White arrowheads, filopodia; yellow arrowheads, Mipp1 enrichment; white dash lines, outline of the trachea; white dash boxes, zoom in area. Scale bars, 5 mm.
See also Figure S3.adult fly wing hair patterns (Figure S6J) or thoracic bristle orien-
tation (data not shown). Thus, Mipp1 likely affects DT length by a
novel mechanism.Cell RepUnfused DB phenotypes can be caused by a lack of fusion cell
fate specification. We confirmed the presence of DB fusion cells
at the appropriate position by staining with the fusion markerorts 13, 2174–2188, December 15, 2015 ª2015 The Authors 2179
Dysfusion (Dys) (Figure S6L), ruling out the possibility that DB
fusion defects are due to changes in fusion cell fates.
Mipp1 Affects Sister-Cell Intercalation
From theMipp1 expression pattern and themipp1KOphenotypes
in the DB and GB, we speculate that Mipp1 facilitates tracheal
branchmigration/elongation. Since the DB defect wasmore pro-
nounced and individual DBcells are easily visualized,we focused
on theDB. TheDBelongates bySCI,which transformsamulticel-
lular tube to a unicellular tube by rearranging cells froma side-by-
side to an end-to-end configuration (Figure S2B) (Ribeiro et al.,
2004). During this cell rearrangement, adherens junctions (AJs)
are remodeled from intercellular to autocellular. We visualized
intercalation by the position of tracheal cells (Tgo) andAJ staining
(ECad), which changes from an intercellular AJ staining pattern
(ring-staining pattern) (Figure S2C0) to an autocellular AJ staining
pattern (line-staining pattern) (Figure S2D0). We quantified the
intercalation statusof eachDBat early st15,when thepercentage
of intercalated DBs in WT was 80% (Figure 7B). Loss ofmipp1
decreased the percentage of intercalated DBs to 62%, a pheno-
type rescued by expressingmipp1 in the trachea (Figure 7B); the
decrease of percentage for successful SCI from 80% for wild-
type to62%formipp1KOcloselymatched thepercentage change
in DB fusion events. Overexpression of mipp1 insignificantly
decreased thepercentageof intercalatedDBs, aphenotype likely
due to the greater increase of filopodia number in the DB stalk
compared to the tip (Figures S7B and S7E). Note that SCI was
completely blocked in trachea where high filopodia numbers
occurred throughout the DB, as observed with en-Gal4-driven
UAS-Bnl expression (Figures S7C and S7D).
Mipp1 Facilitates Filopodia Formation
SCI is induced by the pulling force created by migration of the
distal tip of the branch and attachment of the proximal end of
the branch to the DT (Figure S2) (Caussinus et al., 2008). Filopo-
dia at the distal tip promote the migration of the DB leading cells
(Ribeiro et al., 2002). DB cells are connected though cell-cell
junctions, so trailing DB cells collectively migrate with the leading
cells and rearrange to elongate the DB.mipp1 is highly enriched
at the distal tip of the DB at the onset of filopodia formation (Fig-
ures 2H and S1S). The extensive DB filopodia could also be de-
tected by Mipp1 staining (Figure 3C). We determined filopodia
number in bothmipp1KO embryos and in embryos overexpress-
ing tracheal-specific mipp1 using the membrane marker (Myr-
GFP) at st14 (Figures 7C–7G). Filopodia number was decreased
inmipp1KO and was increased with overexpression of WTMipp1
but not overexpression of enzyme-deadMipp1H67A, ER localized
Mipp1ER, or apically localized Mipp1-GFP (Figure 7G). Hence,
both phosphatase activity and basal/filopodia localization of
Mipp1 are required for Mipp1 function in filopodia formation.
The reduced filopodia number in mipp1KO was rescued by spe-
cifically expressing mipp1 in the trachea (Figure 7G). Thus,
Mipp1 is enriched at the distal tip of the DB to facilitate filopodia
formation in a phosphatase activity-dependent manner.
Mipp1 Gives Migrating Cells the Lead
DB migration and elongation occur with cell rearrangement.
Since leading DB cells have the highest mipp1 expression, we2180 Cell Reports 13, 2174–2188, December 15, 2015 ª2015 The Auasked whether Mipp1 expression affects position of individual
DB cells in the DB. We created bgal, Mipp1, enzyme-dead
Mipp1H67A, or apically localized Mipp1-GFP clones in amipp1KO
homozygous, heterozygous, or WT background at st11, when
primary branching initiates, and determined the position of cell
clones in the DB at late st15, when DB migration and elongation
are mostly complete. Cell clones were marked by nuclear bgal,
and tracheal cell nuclei were marked by Tango (Tgo) (Figure 7H).
The most distal DB cell position was numbered 1, and the
most proximal DB cell position was numbered 6. The bgal and
mipp1H67A clones were evenly distributed from positions 1–6,
whereas the Mipp1 clones preferentially localized to a distal
position andMipp1-GFP clones favored a proximal position (Fig-
ure 7I). Mipp1 normally localizes to the basolateral domain—the
leading edge of migrating cells, whereas Mipp1-GFP localizes
Mipp1 to the apical domain—the lagging edge of migrating cells;
this switch of Mipp1 to the lagging edge appears to compromise
either migration speed or direction. Thus, Mipp1 expression and
proper basolateral localization is sufficient to advance migrating
DB cells to the leading positions, although the advantage is less
notable in trachea expressing the high wild-type levels of Mipp1
in the most distal tracheal cells.
DISCUSSION
Here, we show thatmipp1 is highly and dynamically expressed in
the developing trachea. Whereas expression occurs initially in all
cells, mipp1 mRNA persists in migrating branches, especially in
the distal-most cells. There, mipp1 mRNA forms large foci that
localize to the side of the cell closest to the direction of migration
and filopodia formation. We provide evidence that Drosophila
Mipp1 sits on the cell surface where it dephosphorylates extra-
cellular IP6 to IP3. During primary branching, Mipp1 localization
shifts from being enriched in the apical membrane to the baso-
lateral domain. During DB elongation andmigration,Mipp1 local-
izes to filopodia and is enriched at the distal tip and cell-cell
junctions. We show that Mipp1 facilitates filopodia formation
and enhances cell competitiveness for the lead position of the
DB in a phosphatase-activity-dependent manner, suggesting
either that local depletion of extracellular IP6 or local increases
in lower order IP intermediates (IP5, IP4) or product (IP3) promote
collective tracheal cell migration and branch elongation.
The extracellular localization of Drosophila Mipp1 raises the
question of where Mipp proteins function in other organisms.
In both mammals and Dictyostelium, Mipp has been suggested
to affect intracellular IP profiles (Chi et al., 2000; King et al.,
2010). In Dictyostelium, Li+ treatment reduces the speed
and linear migration path of cAMP-dependent chemotaxis by
lowering IP3 production, cytosolic Ca
2+ levels, and inositol syn-
thesis (Harwood, 2011). Li+ is proposed to exert its effects
through prolyl oligopeptidase (PO), since loss of this enzyme
confers Li+ resistance. Because altering Mipp1 function in-
creases sensitivity to Li+, it has been suggested that PO reduces
cellular IP3 levels by blocking the activity of Mipp1. A model
has been proposed suggesting a role for Mipp1-dependent in-
creases in cellular IP3 levels in elevating transcription of enzymes
required for inositol production (King et al., 2010). One problem
with this model is that both loss and overexpression of Mipp1thors
(legend on next page)
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makes Dictyostelium cells hypersensitive to Li+ treatment (King
et al., 2010). Moreover, Dictyostelium Mipp1 contains a puta-
tive N-terminal signal peptide and C-terminal transmembrane
domain, suggesting that it enters the secretory pathway and traf-
fics to the plasma membrane where it faces the extracellular
space, just like the Drosophila protein. We suggest that Mipp1
loss and overexpression may independently exacerbate the
inhibitory effects of Li+ on cell migration by affecting the polar-
ized distribution of Mipp1 substrates and/or reaction products
in the immediate vicinity of migrating cells.
Recent studies in lung carcinoma cells suggest that mamma-
lian Mipp1 also converts extracellular IP6 to IP3 (Windhorst et al.,
2013). In these cells, Mipp1 localizes not only to the ER, but also
to Golgi/plasma membrane fractions and in the supernatant.
Moreover, the extracellular/secreted Mipp1 could dephosphory-
late extracellular IP6 to IP3 (Windhorst et al., 2013). The authors
suggested that the internalized IP6 was converted to IP5 in the
lysosome, an organelle whose acidic environment is inconsistent
with the optimum pH range of 7.0–7.8 for Mipp1 activity. It is thus
likely that other enzymes are involved in the dephosphorylation
of the internalized IP6. With RNAi knockdown ofmipp1, extracel-
lular conversion of IP6 to IP3 was more reduced compared to
the intracellular dephosphorylation. Altogether, these findings
suggest that extracellular Mipp activity exists in Drosophila, in
Dictyostelium, and in mammalian systems.
IP6 is a key substrate of Mipp and is a well-known anti-tumor
agent. High concentrations of extracellular IP6 (>1 mM) inhibit
migration and proliferation of tumor cells (Shamsuddin et al.,
1997). Breast cancer cells treated with IP6 round up and exhibit
decreased plating efficiency through downregulation of integrin
expression (Tantivejkul et al., 2003a, 2003b). IP6 inhibition of
invasive migration in vitro in matrigel or in vivo during metastasis
has also been demonstrated (Tantivejkul et al., 2003a; Ullah and
Shamsuddin, 1990; Vucenik et al., 1992). These findings suggest
that a critical role for Mipp1 could be to remove local pools of IP6
to allow for attachment and cell migration.
A potential role for extracellular IP6 has been demonstrated
in vitro (Morrison et al., 1994). Heparin association with FGF
facilitates FGF binding to FGF receptor for signal activation (Spi-
vak-Kroizman et al., 1994). IP6 can also bind FGF due to struc-
tural similarities between IP6 and the saccharide residues on
heparin. IP6 binding to FGF blocks FGF association with heparin
and inhibits FGF signal activation (Morrison et al., 1994). In the
trachea, cells expressing the highest levels of FGF receptorFigure 4. Expression of mipp1 Is Activated by FGF Signaling and Repr
Fluorescent in situ hybridization ofmipp1mRNA (green) with immunostaining of M
most distal tip are labeled with 1, 2, and 3. The two DT cells located at the base
(A and A0 ) WT st14 DB and DT.
(B and C) btl (FGF receptor null) (B) and bnl (FGF ligand null) (C) mutants st14 do
(D–E0) bnl overexpression st14 DB and DT.
(F) en-Gal4-driven Myr-GFP expression relative to trachea.
(G and G0) sal-deficient st14 DB and DT.
(H) sal overexpression in st14 DB and DT
(I) kni and knrl-deficient st14 dorsal trachea.
(J and K) Quantification of the relative mipp1 mRNA and Mipp1 protein sum inte
(L) Model of the upstream pathway regulating the Mipp1 expression in trachea.
Asterisks (*), trapping of green mipp1 signals in the tracheal lumen; white arrow
mRNA; white dash lines, outline of the trachea. Scale bars, 5 mm.
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DB (Ghabrial and Krasnow, 2006). Here, we have shown that
expression of Mipp1 similarly increases the competitiveness of
DB cells for the leading position. Mipp1 may deplete local pools
of extracellular IP6, thus enhancing local FGF activity in the distal
tip cells of the migrating DB. Alternatively, Mipp1 at the tips of
migrating cells may change the local extracellular IP profile and
extracellular IPs may bind to other extracellular proteins or re-
ceptors to affect filopodia formation during cell migration.
Early Mipp1 at the apical domain might also promote filopodia
formation. We observed significant overlap between Mipp1
and known filopodia markers in the apical domain during
invagination. Our lab observed dynamic actin-rich filopodia-like
extensions in the apical domain of the invaginating salivary
gland (unpublished data), so perhaps similar structures form in
invaginating tracheal cells. Filopodia at the apical domain might
sense theextracellular environment to control thesizeof the form-
ing apical lumen, perhaps explaining the other tracheal pheno-
type we observe withmipp1 loss: over-elongation of the DT.
In conclusion, we show thatDrosophilaMipp1 functions extra-
cellularly to facilitate filopodia formation to drive tracheal tube
elongation. This single target of FGF signaling provides the
same advantage to migrating cells as having the highest levels
of FGF signal. Importantly, Mipp1 localization to the external sur-
face of the plasma membrane also solves the enigma of how
Mipps access their IP substrates. We expect that our demon-
stration that extracellular pools of IPs affect tissue morphogen-
esis will fuel extensive research into how cells perceive and
respond to such molecules.
EXPERIMENTAL PROCEDURES
Drosophila Strains
btlLG19, bnlP1, Df(2L)Exel6029, Df(3L)ri79c, Df(X)N73, da-GAL4, en-GAL4,
UAS-myr-GFP,UAS-lifeact-GFP,AyGAL-FRT;UAS-lacZ, and hsFLPwere ob-
tained from Bloomington. btl-GAL4 was provided by S. Hayashi. UAS-bnlA1-1
and UAS-bnlA1-2 were provided by M. Krasnow. sage-GAL4 was created by
our lab (Chung et al., 2009).
Generation ofmipp1KO and Transgenicmipp1 Flies
The mipp1 open reading frame (ORF) was replaced by w+ by homologous
recombination (Gong and Golic, 2003). mipp1KO was confirmed by PCR and
in situ hybridization.UAS lineswere createdusing theDrosophilaGatewayVec-
tor system (Carnegie). Themipp1ORFwasPCRamplified and cloned into pTW
and pTWG to generate UAS-mipp1 and UAS-mipp1-GFP, respectively.
Enzyme-dead Mipp1 was made by mutating the histidine at position 67 to anessed by Spalt
ipp1 protein (red) and tracheal nuclear Tgo (blue). The three DB cells located at
of DB are labeled with 7 and 8.
rsal trachea.
nsity per cell for DB and DT using Imaris. Error bars, SEM.
heads, large foci of mipp1 mRNA; yellow arrowheads, small puncta of mipp1
thors
Figure 5. Mipp1 Is GPI Anchored and Dephosphorylates Extracellular Pools of IPs
(A) Cartoon of Mipp1 protein showing histidine phosphatase (HP) domain and hydrophobic N and C termini.
(B) Candidate topologies for Mipp1, which is anchored in the plasma membrane by either its C-terminal hydrophobic span or GPI anchor.
(C and D) Glycosidase treatment of Mipp1 from (C) embryo extracts and from (D) S2 cell extracts.
(E) Extracellular Mipp1 can be detected in unpermeabilized S2 cells expressing Mipp1.
(F) PI-PLC cleavage releases GPI anchored Mipp1 into the extracellular media. p, pellet (cells); S, supernatant (extracellular media).
(G and H) Trachea overexpressing (G) WT mipp1 in amipp1KO (btl > mipp1; mipp1KO) and (H) enzyme dead mipp1 in amipp1KO (btl > mipp1H67A; mipp1KO) co-
stained with Mipp1 (red) and aPKC (apical marker; green).
(I) Trachea overexpressing mipp1-GFP in a mipp1KO (btl > mipp1-GFP; mipp1KO) co-stained with Mipp1 and GFP.
(J) Trachea overexpressing mipp1-GFP (btl > mipp1-GFP) co-stained with GFP and KDEL (ER marker).
(K) Toluidine-blue stained PAGE gel of IP6, IP5, IP4, IP3, and polyphosphate (PolyP) as size indicator.
(L) The reaction products of IP6 added to the media of S2 cells expressing vector, Mipp1, enzyme-dead Mipp1
H67A, or Mipp1-CFP for 30 min.
See also Figure S4.
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Figure 6. Loss of mipp Perturbs DT Tube Length, DB Fusion, and GB Migration to CNS
Luminal morphology of trachea revealed by 2A12 staining.
(A and B) DT luminal morphology of (A) WT and (B) mipp1KO.
(C) Measurement of DT length.
(D–G) DB fusion morphology of (D) WT and (E) mipp1KO, (F) mipp2 deficiency (Df(x)N73), (G) double mutant (Df(x)N73; mipp1KO).
(D0–G0) Zoomed in areas indicated by the white dash boxes.
(H–K) GBmigrationmorphology of (H)WT, (I)mipp1KO, (J)mipp2 deficiency (Df(x)N73), (K) doublemutant (Df(x)N73;mipp1KO). Black dashed line, the CNSmidline;
white dash line, ventral nerve cord (VNC) border; white circle, GB that either does notmigrate beyond the VNCborder or does notmigrate close to the CNSmidline
and turn posteriorly.
(L and M) Quantification of the percentage of (L) fused DBs and (M) correctly migrated GBs.
Error bars, SEM; ns, not significant; *p value <0.05; **p value <0.005; ***p value <0.0001. See also Figures S5 and S6.alanine andGPI-anchor-site-deletedMipp1wasmade by deleting amino acids
439–444, using theQuickChange II Site-DirectedMutagenesis Kit (Stratagene).
All cloning details and primer sequences are available upon request.
Generation of Mipp1 Antiserum
Antiserum was made against full-length Mipp1 excluding the N-terminal 15
amino acids. The mipp1 ORF from nucleotides 46–1404 was cloned into
pET28b vector (Novagen). Protein was purified from Mipp1-expressing BL21
cells by the side-strip method with electro-elution and lyophilization as
described (Harlow and Lane, 1988). Guinea pig polyclonal Mipp1 antiserum
was generated (Covance).2184 Cell Reports 13, 2174–2188, December 15, 2015 ª2015 The AuIn Situ Hybridization
Whole-mount in situ hybridization and fluorescence in situ hybridization were
performed as described (Knirr et al., 1999; Lehmann and Tautz, 1994) using an
anti-sense digoxygenin-labeled mipp1 RNA probe generated from cDNA
GM09242. sano and trh probes were generated in our lab (Chung et al.,
2011; Chung et al., 2009).
Embryo Immunostaining
Embryos were formaldehyde fixed, and immunofluorescence and biotin-con-
jugated horseradish peroxidase (HRP) immunohistochemistry were performed
as described (Reuter et al., 1990). For ECad staining, embryos were fixed inthors
(legend on next page)
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formaldehyde-saturated heptane and devitellinized with EtOH. For Mipp1,
Singed, Enable, and Chickadee staining, embryos were fixed in formaldehyde
or in Bouin’s solution (Sigma) and devitellinized with MeOH. Mipp1-stained fi-
lopodia could be detected with Bouin’s but not formaldehyde fixation. Mipp1
antiserum was used at 1:500 for immunofluorescence and 1:10,000 for HRP
immunostaining. Primary antibodies used for immunostaining were mouse
2A12 (1:10, DHSB), mouse a-bgal (1:500, Promega), mouse a-Chic (1:10,
DHSB), mouse a-Crb (1:10, DHSB), guinea pig a-Cor (1:2000, R. Fehon),
mouse a-Dlg (1:500, DHSB), rabbit a-Dys (1:800, S. Crews), rat a-DE-Cad
(1:10, DHSB), mouse a-Ena (1:20, DHSB), rabbit a-GFP (1:10,000, Invitrogen),
rabbit a-aPKC (1:200, Santa Cruz), rabbit a-SAS (1:500, D. Cavener), mouse
a-Sn (1:10, DHSB), rat a-PH4aSG1 (1:500, Abrams et al., 2006), guinea pig
a-Verm (1:500, C. Samakovlis), WGA-488 (1:1,000, Invitrogen). Fluorescently
labeled (Alexa 488, 555, 647) secondary antibodies were used at a dilution
of 1:500 (Invitrogen). Images were obtained with LSM 510 confocal micro-
scope (Carl Zeiss). Immunohistochemical images were taken with an Axiophot
light microscope (Carl Zeiss) equipped with ProgRes C14PLUS image capture
system. Statistical analyses were performed with unpaired t test.
Generation of Mutant Cell Clones
Fly lines used were (1) AyGAL-FRT, UAS-lacZ; mipp1KO, (2) hs-FLP;mipp1KO,
(3) hs-FLP; mipp1KO, UAS mipp1, (4) hs-FLP; mipp1KO, UAS mipp1H67A, (5)
hs-FLP; mipp1KO, UAS mipp1-GFP, (6) AyGAL-FRT, UAS-lacZ, (7) hs-FLP,
(8) hs-FLP; UAS mipp1, (9) hs-FLP; UAS mipp1H67A, (10) hs-FLP; UAS
mipp1-GFP. Embryos were collected for 2 hr at 25C, aged for 5 hr at 25C,
heat-shocked for 45 min at 37C, and developed for 8 hr at 25C.
Western Blots
Western blot for embryos and S2 cells were performed as described (Abrams
et al., 2013; Ismat et al., 2013). Samples were separated on an 8% SDS-PAGE
gel. Guinea pig a-Mipp1 (1:10,000) and mouse a-btub (1:1,000, DHSB) and
HRP-conjugated secondary antibodies (1:10,000, Invitrogen) were used.
Transfection of S2 Cells with mipp1 Constructs
Themipp1,mipp1H67A,mipp1-CFP,mipp1ER constructs for S2cell transfection
were generated using the Drosophila Gateway Vector system (Carnegie) with
the pAW or pAWC vector. Transient transfections of S2 were performed with
Effectene Transfection Reagent (Sigma) following themanufacturer’s protocol.
S2 Cell Immunofluorescence
S2 cell immunofluorescence was performed as described (Rogers and
Rogers, 2008), except PBS was used from the initial washes through primary
antibody incubation to minimize cell permeability for better detection of mem-
brane localized Mipp1. Guinea pig a-Mipp1 (1:1,000), fluorescently labeled
(Alexa 488 or 555) secondary antibodies (1:1,000, Invitrogen), phalloidin Alexa
546 (1:500 Invitrogen), and DAPI (1:1,000) were used.
Mipp1 Immunostaining of Non-permeabilized Cells
S2 cells were plated on ConA (0.5 mg/ml) coverslips for 1 hr at room temper-
ature (RT), then transferred to a 4C cold room and kept on ice. Cells were
blocked with 5% NGS:PBS for 5 min and incubated with primary antibodies
in 5% NGS:PBS for 30 min on ice. Cells were fixed with 4% formaldehyde in
PBS at RT for 10 min, washed with PBTriton at RT, incubated with secondaryFigure 7. Mipp1 Promotes SCI and Filopodia Formation and Gives Tra
(A and A0) Adherens junctions (ECad) and tracheal nuclei (Tgo) stainings of (A) fu
pattern of AJs for non-intercalated DB.
(B) Quantification of percentage of intercalated DB forWT,mipp1KO,mipp1 overex
(C–F) Trachea filopodia detected with btl-driven expression of Myr-GFP in (C) W
expression. White arrowheads, filopodia.
(G) Quantification of filopodia number (error bars, SEM; ns, not significant; *p va
(H) DB cell position of Mipp1-expressing clones. Clones, nuclear bgal (red); Tgo, t
proximal tracheal cell. Yellow arrowheads, bgal marked clones in DB.
(I) Quantification of the frequency of clone distribution in positions 1–6 of the trac
Scale bars, 5 mm. See also Figures S2 and S7.
2186 Cell Reports 13, 2174–2188, December 15, 2015 ª2015 The Auantibodies in 5% NGS:PBTriton for 1 hr at RT, and washed with PBTriton
at RT.
Glycosidase Digestion
Embryo and S2 cell lysates were digested with PNGase-F (New England Bio-
labs) for 1 hr at 37C, according to the manufacturer’s protocol, and run on
SDS-PAGE. Protein bands were detected by western blots.
PI-PLC Treatment
S2 cells were incubated with PI-PLC (Sigma) at a concentration 0.2 UN/106 cell
in 13 PBS at 37C for 1 hr. The cell pellet and supernatant were separated by
centrifugation at 14,000 rpm for 5 min. Both the cell pellet and supernatant
samples were run on SDS-PAGE and analyzed by western blots. All protein
bands in the supernatant fraction were shifted slightly upward compared to
proteins bands in the cell pellet fraction.
Extracellular Dephosphorylation of IP6 by Mipp1
S2 cells were transfected with the pAW vector,mipp1-pAW,mipp1H67A-pAW,
or mipp1-pAWC. 200 mM IP6 was incubated with 5 3 10
6/100 ml of S2 cells in
PBS for 30 min at 25C. Cells were centrifuged at 14,000 rpm for 10 min, and
the supernatant was kept. IPs in the supernatant were separated on a 37%
PAGE gel overnight at 4C and stained with toluidine blue, as previously
described (Losito et al., 2009). Standard IPs (I(1,3,4,5,6)P5, I(1,3,4,5)P4, and
I(1,4,5)P3) were obtained commercially from Cayman Chemical.
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